AAPS Pharmaceutical Career News
Feb. 14, 2014

We want your feedback!

At AAPS, we continue to see the disciplines within the pharmaceutical industry evolve and shift and realize that the professional development fundamentals required for success are also changing.

In fact, experience tells us how important it is to provide timely professional development topics for our Career Center webinars and program sessions at the AAPS Annual Meeting and Exposition. As we prepare to optimize our future professional development offerings, we are hoping you can help us with your thoughts on what specific topics will assist in expanding your knowledge in a specific area. (i.e., how to transition into consulting, project management, grant writing, etc.).

We will continue to provide resources for résumé reviews, interviewing tips, and our other standard topics, but we would like to complement these sessions with a few new timely topics.

Please feel free to send us your thoughts! You can email them to Kevin Folk at FolkK@aaps.org. Thank you!More

6 Steps to Capitalize on Your Next Networking Event

Networking is one of the best ways to achieve professional growth and career advancement in the bio-pharmaceutical industry. Many of the best job openings are never shared with the public. Without a strong network of colleagues in the industry, you are a lot less likely to be informed about these great opportunities when they arise.

Following these six simple steps will help you identify, prepare for, and attend networking events successfully.

To read more on how to become an effective networker, please refer to our new Career Success section of the AAPS Career Center.More

50 Percent of Pharmaceutical Companies Employ Dedicated Counter-Generics Teams
Nearly 75 percent of surveyed Top 10 and Top 50 pharmaceutical companies use a dedicated counter-generics team structure, revealed a Cutting Edge Information study. Counter-generics teams, whether dedicated to the task or created as-needed for each project, are necessary for any pharmaceutical company facing a product’s patent expiration. The study, “Post-Patent Generic and Biosimilar Defense: Harnessing Competitive Tactics to Mitigate Revenue Erosion,” found that over half of all surveyed companies maintain a dedicated structure for counter-generics planning and implementation.More

The Crucial Career Choices We Make Every Day
By Mike Wokasch
Many of us are in a work routine where we get up, go to work, do our job and go home. We do this without realizing that every day we make two choices that affect our job performance, career opportunities and compensation. These choices also have deeper rooted personal and job satisfaction implications that will become obvious from this discussion. Some people feel comfortable in their job. You feel competent and good about your level of job performance. You might have received commendations for excellent or exceptional performance. Last performance review was nothing but praise.More

Pharmaceutical Firm Adding 230 Jobs
The Kansas City Star
Catalent Pharma Solutions, which currently employs about 50 people at 10245 Hickman Mills Drive, has received a state job-training grant. It will assist Catalent’s plan to hire the 230 people, Rachel Wolf, Catalent’s human relations director, said Monday. Missouri Gov. Jay Nixon and Kansas City Mayor Sly James are to discuss the expansion at an event Tuesday afternoon at the 450,000-square-foot Catalent facility. The company is described as a global leader in the life sciences industry. The building is part of the former Marion Laboratories complex, which also includes the Cerner Innovation Campus.More

Report: Pharma Sector Battling With Fraud Among Job Applicants
Economic Times
It's not just the U.S. Food & Drug Administration that the Indian pharmaceutical sector is wary of, but it has a rather unusual problem to deal with. A staggering 35 out of every 100 job applicants in the pharmaceutical or clinical trial space are lying about their credentials either by furnishing incorrect educational information or, what's even worse, creating fake companies, the highest among any other sector, according to a report released by AuthBridge, a Delhi-based employee screening firm.More

Oracle Announces Oracle Eloqua for Life Sciences
The Wall Street Journal
Marketers in the medical device manufacturing, pharmaceutical, and biotechnology industries face unique challenges in their efforts to reach healthcare providers, payors, and prescription influencers with personalized communications. At the same time, diminishing budgets require more output from less resources, which makes traditional in-person marketing too expensive and inefficient. To help life science organizations address these challenges and better target and engage with key healthcare audiences, Oracle announced Oracle Eloqua for Life Sciences.More

Pharmaceutical Giants to Join US Initiative
Independent Online
Government researchers will collaborate with 10 large pharmaceutical companies on a $230-million initiative to speed development of new medications for major diseases, the U.S. National Institutes of Health announced. The five-year initiative targets Alzheimer's Disease, Type 2 diabetes, rheumatoid arthritis and lupus, and may be expanded to other ailments, the NIH said.More

Immense Opportunities Await Indian Pharma Manufacturing Industry
Immense opportunities are waiting for the Indian pharmaceutical industry, both at the domestic and at the global level, and the future will be extremely promising with many more milestones, according to a research study conducted by Dr G Selvaraju, former director of drugs control, Tamil Nadu for the Vinayaka Mission University, Salem, Tamil Nadu. While there are advantages to take pride in by the industry, there are also challenges to face with by the industry players and those hurdles need to be overcome in order to achieve sustainable growth in the future. Skilled workforce, low labour cost and opportunities for export are the major advantages of the Indian pharma industry, says the study.More

Drug Firms Look to Gulf Region as Next Frontier
The Wall Street Journal
Pharmaceutical companies that specialize in diabetes are targeting the Persian Gulf for investment by forming local partnerships and eying the establishment of manufacturing facilities to cater to the millions of people forecast to develop the disease within the next two decades. The region is one of the next frontiers for those drug companies that are looking for growth and have already invested in developing their businesses in the emerging markets of China, India, Russia and Brazil, consultants say.More

Drug Shortages in US Have Tripled in 5 Years
Despite having a multi-billion-dollar pharmaceutical industry, the United States has continued to struggle with a chronic shortage of important drugs that patients need. The result has been a tripling in the number of annual drug shortages over the past five years. In 2007, the number of drugs in short supply was 154. That total soared to 456 by 2012, according to a new report (pdf) from the Government Accountability Office (GAO).More

Experience And Skills Are No Match For Talent
By Mel Kleiman
Human knowledge is now doubling every 3.7 years. This means 50 percent of what you now know will be out of date in less than four years. Just to bring it home, let's imagine you need open heart surgery. How would you like to have it performed by someone who hadn't learned anything new about the procedure in the past 48 months? For this reason, it is no longer about hiring skills and/or experience. Today, it's all about hiring talent.More